The brief
- Came out of stealth on 6 Oct 2026 with $13.5M led by reMind Capital and General Catalyst.
- Licenses Butterfly Network's Ultrasound-on-Chip; first human study enrolling in Redwood City, California.
Programs
Bridge Neurotech, one program
Updated 10d ago
Research · Proto · Pilot · Deploy · Scaling
Peers
- Merge LabsUltrasound and molecular BCIResearch$850Mprivate
- CognixionAxon-RPilot$32Mprivate
- Arbor Neuroscience (formerly Forest Neurotech)Forest 1 ultrasound platformResearch—
- NIHBRAIN InitiativeResearch—
- CoMindCoMind OneProto—
- OpenwaterOpen-Motion stroke detectorPilot—
- CeribellClarity Rapid-Response EEGDeploy—
- KernelKernel FlowDeploy—
Company & funding
- Raised
- $14Mdisclosed private rounds
- Last round
- Seed6 Oct 2026
- HQ
- US
- Founded
- 2026
| Date | Round | Amount | Post-money | Lead |
|---|---|---|---|---|
| 6 Oct 2026 | Seed | $14M | — | reMind Capital, General Catalyst |
Partners & customers
- Supplier
Multi-year deal (Oct 2026) to license its Ultrasound-on-Chip, with milestone payments and hardware purchases.
- InvestorGeneral Catalyst
Co-led the $13.5M round (Oct 2026).
- InvestorreMind Capital
Co-led the $13.5M round (Oct 2026).
People
- Will Biederman (opens bridgeneurotech.com)Founder and CEO